Cargando…

Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands

INTRODUCTION: The rapid rollout of coronavirus disease 2019 (COVID-19) vaccines for a large proportion of the population necessitates a strong emphasis on safety. Complementary to the existing spontaneous reporting system, The Netherlands Pharmacovigilance Centre Lareb conducted patient-reported coh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kant, Agnes, Jansen, Jurriaan, van Balveren, Leontine, van Hunsel, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936041/ https://www.ncbi.nlm.nih.gov/pubmed/35314943 http://dx.doi.org/10.1007/s40264-022-01151-w

Ejemplares similares

Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Kant, Agnes, et al.
Publicado: (2022)

COVID-19 vaccine reactogenicity – A cohort event monitoring study in the Netherlands using patient reported outcomes
por: Rolfes, Leàn, et al.
Publicado: (2022)

Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature
por: Duijster, Janneke W., et al.
Publicado: (2023)

Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience
por: Oosterhuis, Ingrid, et al.
Publicado: (2022)

Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands
por: van der Boor, Saskia C., et al.
Publicado: (2023)

Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study
por: Kemmeren, J. M., et al.
Publicado: (2021)

Adverse drug reactions of montelukast in children and adults
por: Haarman, Meindina G., et al.
Publicado: (2017)

Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports
por: Ekhart, Corine, et al.
Publicado: (2022)

The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands
por: Rolfes, Leàn, et al.
Publicado: (2016)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Frequency of Adverse Events after Vaccination with Different Vaccinia Strains
por: Kretzschmar, Mirjam, et al.
Publicado: (2006)

Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose
por: Raethke, Monika, et al.
Publicado: (2023)

The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
por: Rolfes, Leàn, et al.
Publicado: (2017)

Correction: Frequency of Adverse Events after Vaccination with Different Vaccinia Strains
por: Kretzschmar, Mirjam, et al.
Publicado: (2006)

The COVID-19 Vaccines: A Description of Adverse Events of Reactions Reported in Kansas
por: Mills, Kale, et al.
Publicado: (2022)

A prediction model‐based algorithm for computer‐assisted database screening of adverse drug reactions in the Netherlands
por: Scholl, Joep H.G., et al.
Publicado: (2017)

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
por: Härmark, Linda, et al.
Publicado: (2020)

Preventable adverse drug events: Descriptive epidemiology
por: Woo, Stephanie A., et al.
Publicado: (2020)

Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center
por: Rollema, Corine, et al.
Publicado: (2022)

Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
por: Härmark, Linda, et al.
Publicado: (2020)

Time to onset in statistical signal detection revisited: A follow‐up study in long‐term onset adverse drug reactions
por: Scholl, Joep H.G., et al.
Publicado: (2019)

Component Analysis of Four Commercial Brands of Gutta-Percha
por: Aminzadeh, Naghmeh, et al.
Publicado: (2006)

Branding Practices on Four Dairies in Kantale, Sri Lanka
por: Adcock, Sarah J. J., et al.
Publicado: (2018)

Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System
por: Jeon, Minji, et al.
Publicado: (2021)

Brand Aid
por: VanAuken, Brad
Publicado: (2014)

The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitors
por: Karimian, Zahra, et al.
Publicado: (2020)

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine
por: Smeets, Tim, et al.
Publicado: (2016)

Curling of Hair in Two Female Patients Taking Alitretinoin
por: Alting, Kim, et al.
Publicado: (2018)

Lead Exposure of Four Biologically Important Common Branded and Non-branded Spices: Relative Analysis and Health Implication
por: Alam, M. Nur E., et al.
Publicado: (2023)

Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases
por: Yaamika, Harshini, et al.
Publicado: (2023)

Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess
por: Yamoah, Peter, et al.
Publicado: (2022)

An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis
por: Liang, Kai-li, et al.
Publicado: (2022)

Signaling COVID-19 Vaccine Adverse Events
por: Harpaz, Rave, et al.
Publicado: (2022)

The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS)
por: Geier, David A., et al.
Publicado: (2012)

EPH174 Adverse Events Associated with COVID-19 and Seasonal Influenza Vaccines: A Retrospective and Descriptive Analysis of CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Reports
por: Alqahtani, Z, et al.
Publicado: (2022)

'Wellcome' Brand Streptococcus Vaccine, Dental
Publicado: (1912)

Statistical heartburn: an attempt to digest four pizza publications from the Cornell Food and Brand Lab
por: van der Zee, Tim, et al.
Publicado: (2017)

Gen Z and Esports: Digitizing the Live Event Brand
por: de Freitas, Rebecca
Publicado: (2020)

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
por: Pan, Xuejiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b98sgonhb7qv4h3nt9jqciiq85